This inventor holds 4 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: University of California, Universitéde Montreal. Active years: 2018-2024.
Company Filing History:
4 out of 15,964 
3 out of 189 
Years Active: 2018-2024
Title: Aimee Edinger: Innovator in Synthetic Sphingolipid-Like Molecules
Introduction
Aimee Edinger is a prominent inventor based in Irvine, CA (US). She has made significant contributions to the field of synthetic sphingolipid-like molecules, focusing on their applications in drug development and treatment methods. With a total of 4 patents, her work is paving the way for innovative therapeutic solutions.
Latest Patents
Aimee Edinger's latest patents include groundbreaking research on synthetic sphingolipid-like molecules. These patents detail small molecules comprised of azacyclic constrained sphingolipid-like compounds, along with methods of their synthesis and treatment applications. The formulations and medicaments she has developed are directed towards treating diseases such as neoplasms and cancers. Her therapeutics contain a therapeutically effective dose of one or more small molecule compounds, which can be administered in various forms, including oral, intravenous, or intramuscular routes.
Career Highlights
Throughout her career, Aimee has worked with esteemed institutions such as the University of California and Université de Montreal. Her research has significantly advanced the understanding and application of synthetic molecules in medicine.
Collaborations
Aimee has collaborated with notable professionals in her field, including Stephen Hanessian. These partnerships have further enriched her research and innovation efforts.
Conclusion
Aimee Edinger's contributions to the field of synthetic sphingolipid-like molecules exemplify her dedication to advancing medical science. Her innovative patents and collaborations highlight her role as a leading inventor in the industry.